4.3 Article

Lidocaine inhibits glioma cell proliferation, migration and invasion by modulating the circEZH2/miR-181b-5p pathway

Journal

NEUROREPORT
Volume 32, Issue 1, Pages 52-60

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WNR.0000000000001560

Keywords

circEZH2; glioma; lidocaine; miR-181b-5p

Categories

Funding

  1. Clinical Research Award of the First Affiliated Hospital of Xi'an Jiaotong University [XJTU1AF-CRF-2019-021]
  2. National Natural Science Foundation of China [81801388]

Ask authors/readers for more resources

This study found that lidocaine can suppress the progression of glioma by modulating the circEZH2/miR-181b-5p pathway. Lidocaine inhibited proliferation, migration, and invasion of glioma cells in vitro, and induced cell differentiation. CircEZH2 was highly expressed in glioma tissues and cells, and partly inhibited the function of lidocaine. Additionally, miR-181b-5p was downregulated in glioma tissues and cells, and its restoration reversed the effects of circEZH2 overexpression on glioma cell behaviors.
Background Lidocaine is well known as a local anesthetic that has been reported to play an antitumor role in numerous cancers, including glioma. Circular RNAs (circRNAs) play multiple biological roles in cancers. The aim of this study was to determine the effects of lidocaine in glioma in vitro and in vivo and explore functional mechanisms. Methods The effects of lidocaine on glioma progression were investigated by cell proliferation, migration and invasion using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay, colony formation assay and transwell assay. The expression of CD133 and glial fibrillary acidic protein (GFAP) was quantified by western blot to assess cell differentiation. The expression of circEZH2 and miR-181b-5p was detected by a quantitative real-time PCR (qRT-PCR). The target relationship between circEZH2 and miR-181b-5p was verified by dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay. The effect of lidocaine on tumor growth in vivo was investigated by establishing Xenograft models. Results Lidocaine inhibited proliferation, migration, invasion and induced differentiation of glioma cells in vitro. Lidocaine suppressed the expression of circEZH2, and circEZH2 was highly expressed in glioma tissues and cells. CircEZH2 overexpression partly inhibited the function of lidocaine. CircEZH2 was a sponge of miR-181b-5p, and miR-181b-5p was downregulated in glioma tissues and cells. Besides, miR-181b-5p restoration reversed the effects of circEZH2 overexpression to repress the malignant behaviors of glioma cells. In addition, lidocaine mediated the circEZH2/miR-181b-5p axis to inhibit tumor growth in vivo. Conclusion Lidocaine suppressed glioma progression by modulating the circEZH2/miR-181b-5p pathway.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available